Pharmaceutical Industry Information Portal


All posts by tag


Moderna aims to roll out a combined flu and COVID vaccine in 2023

The biotechnological company Moderna is working to create a single shot vaccine against both flu and coronavirus by autumn 2023, Moderna's Chief Executive Officer...

Gamaleya Center can develop COVID-19 vaccine based on several strains

Deputy director of the center Denis Logunov specified that a part of the vaccine based on the Wuhan or Delta strain will be able...

WHO Interim Statement on composition of current and future COVID-19 vaccines

Interim Statement on COVID-19 vaccines in the context of the circulation of the Omicron SARS-CoV-2 Variant from the WHO Technical Advisory Group on COVID-19...

Russia develops testing system capable of detecting Omicron coronavirus variant

A testing system capable of simultaneously detecting the coronavirus genome and deciding if it is the Omicron variant of the virus has been developed...

ChemRar Group announces the Russian Avifavir® drug is effective against variants of COVID-19, including Delta and Omicron

ChemRar Group announces the Russian Avifavir® (INN: favipiravir) drug is effective against various variants of SARS-CoV-2 (coronavirus), including Delta and Omicron, as it affects...

Expert Articles